Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens

International Archives of Allergy and Immunology

Volumn 150, Issue 1, 2009, Pages 102-108

  Pfaar, O ^a   Klimek, L ^a   Fischer, I ^a   Sieber, J ^b   Amoroso, S ^d   Moreno Aguilar, C ^e   Shah, K ^c   Mosges R ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Stallergenes GmbH   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d Unita Operativa di Allergologia e Immunologia   (Italy)

^e HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Asthma; Cluster titration; Rhinitis; Subcutaneous immunotherapy

Indexed keywords

ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; HOUSE DUST ALLERGEN; POLLEN ANTIGEN;

ADULT; ALDER; ALLERGIC ASTHMA; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ANAPHYLAXIS; ARTICLE; ASTHENIA; ASTHMA; BIRCH; CHEST TIGHTNESS; COMMON COLD; COST CONTROL; COUGHING; DERMATOPHAGOIDES; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FEMALE; GRASS POLLEN; HEADACHE; HUMAN; IMMUNOTHERAPY; INJECTION SITE REACTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; NOSE CONGESTION; OLIVE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHINOCONJUNCTIVITIS; SYNCOPE; URTICARIA;

ADOLESCENT; ADULT; ALLERGENS; ANIMALS; ASTHMA; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; MALE; MIDDLE AGED; POLLEN; PYROGLYPHIDAE; RHINITIS, ALLERGIC, SEASONAL; YOUNG ADULT;

EID: 63349083457     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210436     Document Type: Article

References (23)

1. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al: Allergic rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and Aller- Gen). Allergy 2008;63(suppl 86):8-160.
2. Bousquet J, Lockey RF, Malling HJ: WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;53:1-42.
3. Bousquet J, Calvayrac P, Guerin B, Hejjaoui A, Dhivert H, Hewitt B, Michel FB: Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. 1. In vivo and in vitro parameters after a short course of treatment. J Allergy Clin Immunol 1985;76:734-744.
4. Bousquet J, Hejjaoui A, Dhivert H, Clauzel AM, Michel FB: Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol 1989;83:797-802.
5. Iliopoulos O, Proud D, Adkinson NF Jr, Creticos PS, Norman PS, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM: Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol 1991;87:855-866.
6. Kang BC, Johnson J, Morgan C, Chang JL: The role of immunotherapy in cockroach asthma. J Asthma 1988;25:205-218.
7. Bousquet J, Hejjaoui A, Soussana M, Michel FB: Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. 4. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. J Allergy Clin Immunol 1990;85:490-497. (Pubitemid 20075183)
8. Bousquet J, Maasch H, Martinot B, Hejjaoui A, Wahl R, Michel FB: Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. 2. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol 1988;82:439-446.
9. Klimek L, Wolf H, Mewes T, Dormann D, Reske-Kunz A, Schnitker J, Mann W: The effect of short-term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secretions. J Allergy Clin Immunol 1999;103:47-53. (Pubitemid 29063190)
10. Pfaar O, Klimek L: Cluster immunotherapy in allergic rhinoconjunctivitis. Hautarzt 2006;57:875-880.
11. Larenas-Linnemann D, Cox LS: European allergen extract units and potency: review of available information. Ann Allergy Asthma Immunol 2008;100:137-145. (Pubitemid 351238549)
12. Position paper: immunotherapy. The European Academy of Allergology and Clinical Immunology (EAACI). Allergy 1993;48:7-35.
13. Mellerup MT, Hahn GW, Poulsen LK, Malling H: Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side effects during induction treatment. Clin Exp Allergy 2000;30:1423-1429.
14. Moreno C, Fernandez-Tavora L, Acero S, Alonso MD, Barahona MJ, Blanco R, Cistero A, Conde J, Fernandez J, Fernandez S, Fernandez- Rivas M, Garcia BE, Garcia-Rodriguez R, Camacho E, Gonzalez-Quevedo T, Gonzalo A, Guardia P, Sanchez-Cano M, Tabar AI, de la Torre F: Tolerance of a cluster schedule on the treatment of seasonal allergic respiratory disease with pollen extracts quantified in mass units. J Investig Allergol Clin Immunol 2003;13:221-227. (Pubitemid 38160363)
15. Tabar AI, Fernandez-Tavora L, Alonso R, Castillo R, Cistero-Bahima A, de la Torre- Morin F, Fernandez J, Garcia-Figueroa BE, Fernandez S, Garcia-Gonzalez JJ, Garcia- Robaina JC, Moreno F, Lobaton P, Sanchez- Machin I, de la Torre-Martinez F: Tolerance of a cluster schedule with a house dust mite extract quantified in mass units: multicentre study. J Investig Allergol Clin Immunol 2004;14:193-197. (Pubitemid 39390275)
16. Tabar AI, Echechipia S, Garcia BE, Olaguibel JM, Lizaso MT, Gomez B, Aldunate MT, Martin S, Marcotegui F: Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus. J Allergy Clin Immunol 2005;116:109-118.
17. Mauro M, Russello M, Alesina R, Sillano V, Alessandrini A, Dama A, Passalacqua G, Senna G: Safety and pharmacoeconomics of a cluster administration of mite immunotherapy compared to the traditional one. Eur Ann Allergy Clin Immunol 2006;38:31-34. (Pubitemid 43226941)
18. Walker SM, Pajno GB, Lima MT, Wilson DR, Durham SR: Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol 2001;107:87-93. (Pubitemid 32105250)
19. Tabar AI, Muro MD, Garcia BE, Alvarez MJ, Acero S, Rico P, Olaguibel JM: Dermatophagoides pteronyssinus cluster immunotherapy. A controlled trial of safety and clinical efficacy. J Investig Allergol Clin Immunol 1999;9:155-164.
20. Hansen I, Hormann K, Stuck BA, Schneider- Gene S, Mosges R, Klimek L: Cluster-immunotherapy in seasonal allergic rhinitis: safety aspects of induction therapy with depot allergoids (Purethal). Laryngorhinootologie 2003;82:558-563. (Pubitemid 37055560)
21. Subiza J, Feliu A, Subiza JL, Uhlig J, Fernandez- Caldas E: Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment. Clin Exp Allergy 2008;38:987-994. (Pubitemid 351725861)
22. Paranos S, Petrovic S: Early effects of rush immunotherapy with Dermatophagoides pteronyssinus in asthmatics. J Investig Allergol Clin Immunol 1997;7:588-595.
23. Moreno C, Cuesta-Herranz J, Fernandez- Tavora L, Alvarez-Cuesta E: Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases. Clin Exp Allergy 2004;34:527-531. (Pubitemid 38534882)